303 related articles for article (PubMed ID: 8548339)
1. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339
[TBL] [Abstract][Full Text] [Related]
2. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line.
Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581
[TBL] [Abstract][Full Text] [Related]
3. Alteration of thymidine kinase activity in cells treated with an antiviral agent.
Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F
J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells.
Hoever G; Groeschel B; Chandra P; Doerr HW; Cinatl J
Int J Mol Med; 2003 Jun; 11(6):743-7. PubMed ID: 12736716
[TBL] [Abstract][Full Text] [Related]
5. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
Avramis VI; Kwock R; Solorzano MM; Gomperts E
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene.
Gröschel B; Höver G; Doerr HW; Cinatl J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):487-92. PubMed ID: 11563064
[TBL] [Abstract][Full Text] [Related]
7. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine.
Turriziani O; Scagnolari C; Bambacioni F; Bellomi F; Focher F; Gentile M; Antonelli G
Antivir Ther; 2002 Jun; 7(2):105-11. PubMed ID: 12212922
[TBL] [Abstract][Full Text] [Related]
8. Further study of the mechanism underlying the cellular resistance to AZT.
Turriziani O; Antonelli G; Focher F; Bambacioni F; Dianzani F
Biochem Biophys Res Commun; 1996 Nov; 228(3):797-801. PubMed ID: 8941356
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase.
Antonelli G; Turriziani O; Verri A; Narciso P; Ferri F; D'Offizi G; Dianzani F
AIDS Res Hum Retroviruses; 1996 Feb; 12(3):223-8. PubMed ID: 8835200
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
13. Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine.
Cases-González CE; Franco S; Martínez MA; Menéndez-Arias L
J Mol Biol; 2007 Jan; 365(2):298-309. PubMed ID: 17070543
[TBL] [Abstract][Full Text] [Related]
14. Use of herpes simplex virus thymidine kinase to improve the antiviral activity of zidovudine.
Guettari N; Loubière L; Brisson E; Klatzmann D
Virology; 1997 Sep; 235(2):398-405. PubMed ID: 9281520
[TBL] [Abstract][Full Text] [Related]
15. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
Degrève B; De Clercq E; Balzarini J
Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and genetical analysis of AZT-resistant HIV-mutants.
Biesert L; Zimmermann F; Schröder B; Matthes E; Suhartono H; Dietrich U; Rübsamen-Waigmann H
Behring Inst Mitt; 1991 Jul; (89):74-80. PubMed ID: 1930105
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine.
Savaraj N; Wu C; Wangpaichitr M; Kuo MT; Lampidis T; Robles C; Furst AJ; Feun L
Int J Oncol; 2003 Jul; 23(1):173-9. PubMed ID: 12792791
[TBL] [Abstract][Full Text] [Related]
19. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
Kerr SG; Anderson KS
Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation and cytotoxicity of therapeutic nucleoside analogues: a comparison of alpha and gamma herpesvirus thymidine kinase suicide genes.
Cazaux C; Tiraby M; Loubiere L; Haren L; Klatzmann D; Tiraby G
Cancer Gene Ther; 1998; 5(2):83-91. PubMed ID: 9570299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
